{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T08:00:03Z","timestamp":1722758403480},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"PAPES","award":["401801\/2015-2"],"award-info":[{"award-number":["401801\/2015-2"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.intimp.2018.04.044","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T03:20:45Z","timestamp":1525663245000},"page":"179-188","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["HIV aspartyl protease inhibitors modify the percentage of activated leukocytes, as well as serum levels of IL-17A and NO during experimental leishmaniasis"],"prefix":"10.1016","volume":"60","author":[{"given":"Daniele Lu\u00edsa Ribeiro","family":"Alvarenga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Helen dos Santos","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline Ara\u00fajo","family":"Fiuza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya Torres","family":"Gaze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaquelline Germano","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Corr\u00eaa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Eduardo","family":"Calzavara-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Ant\u00f4nio","family":"Pascoal-Xavier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9rica Alessandra Rocha","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2018.04.044_bb0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ijid.2011.03.021","article-title":"Recent advances in leishmaniasis treatment","volume":"15","author":"Tiuman","year":"2011","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.intimp.2018.04.044_bb0010","first-page":"147","article-title":"Leishmaniasis\u2013HIV coinfection: current challenges","volume":"8","author":"Lindoso","year":"2016","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"key":"10.1016\/j.intimp.2018.04.044_bb0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12026-013-8389-8","article-title":"The immunology of Leishmania\/HIV co-infection","volume":"56","author":"Okwor","year":"2013","journal-title":"Immunol. Res."},{"key":"10.1016\/j.intimp.2018.04.044_bb0020","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/0974-777X.68528","article-title":"Human immunodeficiency virus and leishmaniasis","volume":"2","author":"Ezra","year":"2010","journal-title":"J. Global Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2018.04.044_bb0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10\u202fyears","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.intimp.2018.04.044_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001153","article-title":"Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review","volume":"5","author":"Cota","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.intimp.2018.04.044_bb0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4269\/ajtmh.2009.09-0077","article-title":"Case report: Tegumentary leishmaniasis as the cause of immune reconstitution inflammatory syndrome in a patient co-infected with human immunodeficiency virus and Leishmania guyanensis","volume":"81","author":"Chrusciak-Talhari","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.intimp.2018.04.044_bb0040","first-page":"95","article-title":"HIV protease inhibitors: a review of molecular selectivity and toxicity","volume":"7","author":"Lv","year":"2015","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"issue":"1","key":"10.1016\/j.intimp.2018.04.044_bb0045","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1128\/CVI.00130-07","article-title":"Direct effect of human immunodeficiency virus protease inhibitors on neutrophil function and apoptosis via calpain inhibition","volume":"14","author":"Hadad","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.intimp.2018.04.044_bb0050","doi-asserted-by":"crossref","first-page":"47840","DOI":"10.1074\/jbc.M105582200","article-title":"Differential effects of HIV-1 protease inhibitors on dendritic cell immunophenotype and function","volume":"276","author":"Gruber","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2018.04.044_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.1996.tb00920.x","article-title":"CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model","volume":"153","author":"Van Gool","year":"1996","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2018.04.044_bb0060","doi-asserted-by":"crossref","first-page":"13120","DOI":"10.1073\/pnas.95.22.13120","article-title":"An inhibitor of HIV-1 protease modulates proteasoma activity, antigen presentation and cell responses","volume":"95","author":"Andr\u00e9","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2018.04.044_bb0065","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/AAC.00625-06","article-title":"Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice","volume":"50","author":"Prot","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.intimp.2018.04.044_bb0070","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.parint.2012.04.006","article-title":"Effect of HIV protease inhibitors on New World Leishmania","volume":"61","author":"Demarchi","year":"2012","journal-title":"Parasitol. Int."},{"issue":"12","key":"10.1016\/j.intimp.2018.04.044_bb0075","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1086\/652870","article-title":"Immunopathological studies of Leishmania amazonensis infection in resistant and in susceptible mice","volume":"201","author":"Cardoso","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2018.04.044_bb0080","series-title":"Schalm's Veterinary Hematology","first-page":"821","article-title":"Normal hematology of the horse and donkey","author":"Grondin","year":"2010"},{"key":"10.1016\/j.intimp.2018.04.044_bb0085","series-title":"Schalm's Veterinary Hematology","first-page":"298","article-title":"Monocytes and macrophages and their disorders","author":"Weiss","year":"2010"},{"issue":"5","key":"10.1016\/j.intimp.2018.04.044_bb0090","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1046\/j.1365-2281.1999.00200.x","article-title":"Different plasma levels of nitric oxide in arterial and venous blood","volume":"19","author":"Cicinelli","year":"1999","journal-title":"Clin. Physiol. Funct. Imaging"},{"issue":"1","key":"10.1016\/j.intimp.2018.04.044_bb0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijantimicag.2005.04.003","article-title":"Antileishmanial activity of HIV protease inhibitors","volume":"26","author":"Savoia","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"9","key":"10.1016\/j.intimp.2018.04.044_bb0100","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1086\/592280","article-title":"Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors","volume":"198","author":"Trudel","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2018.04.044_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000642","article-title":"Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress\u2013mediated, caspase-independent apoptosis in Leishmania amastigotes","volume":"4","author":"Kumar","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2018.04.044_bb0110","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1096\/fj.10-178947","article-title":"HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites","volume":"25","author":"White","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2018.04.044_bb0115","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/jac\/dks410","article-title":"Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients","volume":"68","author":"Santos","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.intimp.2018.04.044_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cyto.990030112","article-title":"Light scatter analysis and sorting of cells activated in mixed leukocyte culture","volume":"3","author":"MacDonald","year":"1982","journal-title":"Cytometry"},{"issue":"8","key":"10.1016\/j.intimp.2018.04.044_bb0125","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/cyto.a.21096","article-title":"Forward light scatter is a simple measure of T-cell activation and proliferation but is not universally suited for doublet discrimination","volume":"79(","author":"B\u00f6hmer","year":"2011","journal-title":"Cytometry"},{"issue":"3","key":"10.1016\/j.intimp.2018.04.044_bb0130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1590\/S0001-37652004000300006","article-title":"The T-cell anergy induced by Leishmania amazonensis antigens is related with defective antigen presentation and apoptosis","volume":"76","author":"Pinheiro","year":"2004","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.intimp.2018.04.044_bb0135","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2741\/1230","article-title":"Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo","volume":"9","author":"Cooper","year":"2004","journal-title":"Front. Biosci."},{"issue":"11","key":"10.1016\/j.intimp.2018.04.044_bb0140","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1096\/fj.03-1230com","article-title":"Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis","volume":"18","author":"Weaver","year":"2004","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.intimp.2018.04.044_bb0145","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.molmed.2013.07.006","article-title":"Is CD69 an effective brake to control inflammatory diseases?","volume":"19","author":"Gonz\u00e1lez-Amaro","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2018.04.044_bb0150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/imm.12272","article-title":"Sphingosine-1-phosphate receptor 1 signalling T cells: trafficking and beyond","volume":"142","author":"Garris","year":"2014","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.intimp.2018.04.044_bb0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0046-8177(78)80007-0","article-title":"The circulating \u201catypical\u201d lymphocyte","volume":"9","author":"Shiftan","year":"1978","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.intimp.2018.04.044_bb0160","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1128\/IAI.61.7.2952-2959.1993","article-title":"Immune responses associated with susceptibility of C57BL\/10 mice to Leishmania amazonensis","volume":"61","author":"Afonso","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2018.04.044_bb0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1074-7613(00)80434-3","article-title":"Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection","volume":"4","author":"Soong","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2018.04.044_bb0170","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.4049\/jimmunol.167.8.4534","article-title":"Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4-T cells in vivo","volume":"167","author":"Qi","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.04.044_bb0175","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1128\/IAI.71.8.4278-4288.2003","article-title":"Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis","volume":"71","author":"Ji","year":"2003","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.intimp.2018.04.044_bb0180","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1128\/IAI.72.2.988-995.2004","article-title":"Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis","volume":"72","author":"Qi","year":"2004","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.intimp.2018.04.044_bb0185","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.4049\/jimmunol.171.7.3705","article-title":"The role of interleukin-10 in susceptibility of BALB\/c mice to infection with Leishmania mexicana and Leishmania amazonensis","volume":"171","author":"Padigel","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.04.044_bb0190","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/eji.200838535","article-title":"Induction, function and regulation of IL-17-producing T cells","volume":"38","author":"Mills","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2018.04.044_bb0195","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.4049\/jimmunol.0713598","article-title":"IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice","volume":"182","author":"Kostka","year":"2009","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2018.04.044_bb0200","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.intimp.2018.04.044_bb0205","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1084\/jem.20122494","article-title":"T cell\u2013derived inducible nitric oxide synthase switches off TH17 cell differentiation","volume":"210","author":"Yang","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2018.04.044_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/203818","article-title":"Reactive oxygen species and nitric oxide in cutaneous leishmaniasis","volume":"2012","author":"Horta","year":"2012","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.intimp.2018.04.044_bb0215","article-title":"Antileishmanial activity and inducible nitric oxide synthase activation by RuNO complex","volume":"2016","author":"Orsini","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.intimp.2018.04.044_bb0220","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.intimp.2014.12.025","article-title":"Anti-HIV drugs, lopinavir\/ritonavir and atazanavir, modulate innate immune response triggered by Leishmania in macrophages: the role of NF-\u03baB and PPAR-\u03b3","volume":"24","author":"Alves","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"6662","key":"10.1016\/j.intimp.2018.04.044_bb0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2018.04.044_bb0230","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.cyto.2012.12.029","article-title":"RelB\/p50 regulates TNF production in LPS-stimulated dendritic cells and macrophages","volume":"61","author":"Gasparini","year":"2013","journal-title":"Cytokine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918301954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918301954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T16:50:30Z","timestamp":1604249430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918301954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":46,"alternative-id":["S1567576918301954"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.04.044","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV aspartyl protease inhibitors modify the percentage of activated leukocytes, as well as serum levels of IL-17A and NO during experimental leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}